Puma Biotechnology (PBYI) Other financing activities (2010 - 2024)

Puma Biotechnology (PBYI) has 11 years of Other financing activities data on file, last reported at $150000.0 in Q3 2024.

• Quarterly Other financing activities changed N/A year-over-year to $150000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2025 was $150000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $130000.0, down 13.33% from the prior year.
• Other financing activities slipped to $150000.0 in Q3 2024, from $2.5 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $10.0 million in Q1 2022 to a low of -$45000.0 in Q4 2020.
• A 3-year average of $2.5 million and a median of $150000.0 in 2024 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 43.42% in 2020, down 4400.0% in 2020.
• Tracing PBYI's Other financing activities over 3 years: stood at -$45000.0 in 2020, then soared by 5655.56% to $2.5 million in 2022, then plunged by 94.0% to $150000.0 in 2024.
• The last three Other financing activities figures came in at $150000.0 (Q3 2024), $2.5 million (Q4 2022), and $10.0 million (Q1 2022), per Business Quant data.